{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:09:45Z","timestamp":1794442185302,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijbiomac.2026.152221","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:29:13Z","timestamp":1777073353000},"page":"152221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery and mechanistic exploration of natural butyrylcholinesterase inhibitors via integrated virtual screening and multidisciplinary approaches"],"prefix":"10.1016","volume":"364","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiana","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"lizi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152221_bb0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on Alzheimer\u2019s disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2018.12.006","article-title":"Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies","volume":"174","author":"Sharma","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152221_bb0015","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"15056","key":"10.1016\/j.ijbiomac.2026.152221_bb0020","first-page":"1","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152221_bb0025","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"issue":"6150","key":"10.1016\/j.ijbiomac.2026.152221_bb0030","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia","volume":"2","author":"Perry","year":"1978","journal-title":"Br. Med. J."},{"issue":"47","key":"10.1016\/j.ijbiomac.2026.152221_bb0035","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152221_bb0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbr.2011.07.035","article-title":"Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-beta peptide in mice","volume":"225","author":"Furukawa-Hibi","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152221_bb0045","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1471-4159.2006.04347.x","article-title":"Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity","volume":"100","author":"Hartmann","year":"2007","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152221_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity","volume":"61","author":"Kosak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","article-title":"Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"132","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuint.2014.12.009","article-title":"Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer\u2019s disease in a southern Brazilian population","volume":"81","author":"Bono","year":"2015","journal-title":"Neurochem. Int."},{"issue":"42","key":"10.1016\/j.ijbiomac.2026.152221_bb0065","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products*","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152221_bb0070","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/med.21745","article-title":"Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer\u2019s disease, and fat metabolism","volume":"41","author":"Xing","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152221_bb0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02815095","article-title":"Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients","volume":"30","author":"G\u00f3mez-Ramos","year":"1997","journal-title":"Mol. Chem. Neuropathol."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2026.152221_bb0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.06.053","article-title":"N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine","volume":"572","author":"Cerbai","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Kosak","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152221_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1039\/C0NP00027B","article-title":"Natural products as a source of Alzheimer\u2019s drug leads","volume":"28","author":"Williams","year":"2011","journal-title":"Nat. Prod. Rep."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152221_bb0095","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4103\/1673-5374.253509","article-title":"Exploring the efficacy of natural products in alleviating Alzheimer\u2019s disease","volume":"14","author":"Deshpande","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2026.152221_bb0100","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cbi.2008.04.049","article-title":"Potential therapeutic targets of huperzine A for Alzheimer\u2019s disease and vascular dementia","volume":"175","author":"Zhang","year":"2008","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152221_bb0105","first-page":"152","article-title":"Neuroprotective effect of quercetin in neurotoxicity induced rats: role of neuroinflammation in neurodegeneration","volume":"7","author":"Pany","year":"2014","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152221_bb0110","doi-asserted-by":"crossref","first-page":"13545","DOI":"10.1038\/s41598-018-31787-7","article-title":"A soy protein Lunasin can ameliorate amyloid-beta 42 mediated neurodegeneration in Drosophila eye","volume":"8","author":"Sarkar","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152221_bb0115","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.bmcl.2019.03.024","article-title":"Bioactivity-guided identification of flavonoids with cholinesterase and \u03b2-amyloid peptide aggregation inhibitory effects from the seeds of Millettia pachycarpa","volume":"29","author":"Tu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152221_bb0120","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00044-017-2108-2","article-title":"Anticholinesterase, antioxidant, and beta-amyloid aggregation inhibitory constituents from Cremastra appendiculata","volume":"27","author":"Tu","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139253","article-title":"Molecular insights into vasicine and butyrylcholinesterase interactions: a complimentary biophysical, multi-spectroscopic, and computational study","volume":"292","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152221_bb0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev-biochem-030222-120000","article-title":"The art and science of molecular docking","volume":"93","author":"Paggi","year":"2024","journal-title":"Annu. Rev. Biochem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152221_bb0135","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103294","article-title":"Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening","volume":"92","author":"Yang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cbi.2019.05.051","article-title":"Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds","volume":"308","author":"Zhou","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.152221_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127609","article-title":"Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening","volume":"30","author":"Miles","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152221_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015939","article-title":"TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108788","article-title":"N-substituted phthalimide-carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: synthesis, mechanistic insights, and cancer-relevant profiling","volume":"163","author":"Zognjani","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118416","article-title":"Phthalimide-benzoic acid hybrids as potent aldose reductase inhibitors: synthesis, enzymatic kinetics, and in silico characterization","volume":"131","author":"Hoti","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0175","article-title":"Chalcone-inspired indole, carbazole, and phenothiazine hybrids as potent aldose reductase inhibitors with selective anticancer potential: rational design, synthesis, and multi-level characterization","volume":"164","author":"G\u00c3\u00bcle\u00c3\u00a7","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijbiomac.2022.01.136","article-title":"Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach","volume":"203","author":"Ganeshpurkar","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.152221_bb0185","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0190","article-title":"Molecular and structural characterization of ureido-benzenesulfonamides as dual inhibitors of aldose reductase and cholinesterases","volume":"773","author":"T\u00c3\u00bcrke\u00c5\u0178","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152221_bb0195","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3109\/14756366.2011.618990","article-title":"Prediction of estrogen receptor beta ligands potency and selectivity by docking and MM-GBSA scoring methods using three different scaffolds","volume":"27","author":"Balaji","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.152221_bb0200","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1021\/jm060522a","article-title":"Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring","volume":"49","author":"Lyne","year":"2006","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152221_bb0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.152221_bb0210","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152221_bb0215","doi-asserted-by":"crossref","first-page":"13649","DOI":"10.1038\/s41598-022-17912-7","article-title":"Biological evaluation, molecular modeling and dynamics simulation of phenanthrenes isolated from Bletilla striata as butyrylcholinesterase inhibitors","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.152221_bb0220","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","article-title":"The blood-brain barrier (BBB) score","volume":"62","author":"Gupta","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152221_bb0225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd3139","article-title":"Virtual screening: an endless staircase?","volume":"9","author":"Schneider","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.152221_bb0230","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2174\/1568026619666190816101948","article-title":"Virtual screening techniques in drug discovery: review and recent applications","volume":"19","author":"da Silva Rocha","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152221_bb0235","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/jphp.12081","article-title":"Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer\u2019s disease treatment","volume":"65","author":"Pinho","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152221_bb0240","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1016\/S0031-9422(00)82519-4","article-title":"Picrasidine T, a dimeric \u03b2-carboline alkaloid from Picrasma quassioides","volume":"26","author":"Koike","year":"1987","journal-title":"Phytochemistry"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152221_bb0245","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1248\/cpb.33.3356","article-title":"Studies on the alkaloids from Picrasma quassioides IV: structures of Picrasidines 1, J, and K","volume":"33","author":"K.K. Ohmoto","year":"1985","journal-title":"Chem. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152221_bb0250","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1159\/000481874","article-title":"Picrasidine I from Picrasma quassioides suppresses osteoclastogenesis via inhibition of RANKL induced signaling pathways and attenuation of ROS production","volume":"43","author":"Wang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103258","article-title":"Effects of Picrasma quassioides and its active constituents on Alzheimer\u2019s disease in vitro and in vivo","volume":"92","author":"Guo","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152221_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.806984","article-title":"Therapeutic mechanism and key alkaloids of Uncaria rhynchophylla in Alzheimer\u2019s disease from the perspective of pathophysiological processes","volume":"12","author":"Zeng","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152221_bb0265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jep.2010.11.063","article-title":"Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells","volume":"134","author":"Kawakami","year":"2011","journal-title":"J. Ethnopharmacol."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.152221_bb0270","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1016\/j.bmc.2012.09.040","article-title":"Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine","volume":"20","author":"Brunhofer","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.152221_bb0275","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.phymed.2018.09.199","article-title":"Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease","volume":"54","author":"Jiang","year":"2019","journal-title":"Phytomedicine"},{"issue":"42","key":"10.1016\/j.ijbiomac.2026.152221_bb0280","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026021483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026021483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:53:44Z","timestamp":1789998824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026021483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"alternative-id":["S0141813026021483"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152221","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and mechanistic exploration of natural butyrylcholinesterase inhibitors via integrated virtual screening and multidisciplinary approaches","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152221"}}